Local media reported Monday that Indian companies have inked an agreement with the Council of Scientific and Industrial Research’s Indian Institute of Chemical Technology (CSIR-IICT) to expand the use of mRNA as a vaccine development platform in the country.

The Hindu Business Line named vaccine supplier Bharat Biotech International Limited, animal health company Biovet, and biotech Sapigen Biologix as signatories.

Only Pune-headquartered Gennova Biopharma is currently using mRNA…